Consumer Defensive Stocks Now Heated But Opportunities Remain
Tobacco and alcohol look attractive.
Tobacco and alcohol look attractive.
The consumer defensive sector trailed the broader market’s impressive rebound this quarter, generating an 11.8% return compared with the market’s 23.1% gain through June 23.
Consumer defensive has underperformed the broader market. - source: Morningstar
Despite this, we think the space has become more heated, such that the median stock in our coverage now trades at just a 1% discount to our fair value estimates. This runs in contrast to the 14% discount the aggregated space boasted three months ago. Consumer packaged goods and nonalcoholic beverages offered bargains at the onset of the pandemic in the U.S., but shares have since bounced. However, we still believe there are values in the sector. Specifically, tobacco and alcoholic beverages provide opportunities, trading at 26% and 16% discounts to our valuations, respectively.
Tobacco and alcoholic beverages look most attractive. - source: Morningstar
When shelter-in-place mandates were announced, consumers rushed to stock their pantries with essential fare. Because of the rapid rise in purchases, which prompted out-of-stocks or limited supplies of certain items, manufacturers halted previously slated promotions. This is shown in an index by Numerator, a market research firm, of top promoted grocery products. Compared with the same week in 2019, products sold on promotion across a number of categories since March 2020 are tracking lower, with a reading of under 100 signifying fewer items sold on promotion than the period last year. The initial buying surge has waned and lockdowns have lifted, so items sold on sale have begun to edge higher. We think promotions may persist if a prolonged recession ensues. However, given a lack of switching costs, we think firms across the sector will need to invest in R&D and marketing to ensure their brands and retail relationships aren’t impaired.
Items sold on promotion have started to rebound as lockdowns ease. - source: Morningstar
Protein price increases have been more pronounced since April, which we attribute partially to disrupted production at several meat processing plants due to the spread of COVID-19. These jobs are labor-intensive, with workers in proximity, impeding social distancing efforts. Beef and pork producers have been disproportionately affected (30%-35% industrywide) compared with poultry (4%-5%), as beef and pork plants tend to be larger, with more employees. While increased safety and sanitation costs are likely to persist, beef and pork profit margins should hold up because of lower livestock costs and higher selling prices.
Beef, chicken, and pork chalked up hearty price increases since April. - source: Morningstar
Top Picks
Anheuser-Busch InBev (BUD)
Economic Moat Rating: Wide
Fair Value Estimate: $96
Fair Value Uncertainty: Medium
We think investors should consider wide-moat Anheuser-Busch InBev, trading about 50% below our assessment of intrinsic value. Although sales have taken a hit from coronavirus disruptions, we expect revenue to pick up when social distancing guidelines are relaxed (about 33% of 2019 sales were on-premises) and to grow high single digits in 2021. AB InBev is the most leveraged among the brewing group, but we think the firm has enough liquidity to operate through the pandemic. We believe the firm is well positioned for the long term, with monopolylike positions and cost advantages in developing markets that continue to generate value.
Pilgrim's Pride (PPC)
Economic Moat Rating: None
Fair Value Estimate: $34.50
Fair Value Uncertainty: High
We consider Pilgrim's Pride an attractive investment, with shares trading almost 50% below our fair value estimate. Pilgrim's CEO has temporarily stepped aside after being indicted on criminal charges of price fixing, with the trial set for August, but we think the business remains attractive. We believe Pilgrim's is poised to benefit from China removing its ban on imports of U.S. chicken and from the global protein shortage caused by African swine fever. And even amid the coronavirus pandemic and its 50% food-service exposure (which skews toward quick-service restaurants), we expect strength in retail to largely offset weak restaurant sales.
US Foods Holding (USFD)
Economic Moat Rating: None
Fair Value Estimate: $31
Fair Value Uncertainty: Medium
Shares of no-moat US Foods trade around a 40% discount to our intrinsic value. Consumers avoided away-from-home food consumption during the pandemic, and as such, the food-service industry slowed, which hasn’t spared any operator. Despite the hit to sales, we expect US Food’s growth to gradually improve in the second half of 2020 as customers revert to prior habits. And we don’t believe this slowdown has hampered its liquidity profile. Although we’ve ratcheted back our fair value estimate for US Foods by 17% since the start of the pandemic, shares are down 54% year to date, creating an attractive opportunity.
Erin Lash does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.